63
Participants
Start Date
July 5, 2019
Primary Completion Date
January 10, 2024
Study Completion Date
January 31, 2026
Pembrolizumab
Patients will receive best supportive care + pembrolizumab 200mg every 3 weeks for a maximum duration of 24 months
Aberdeen Royal Infirmary (NHS Grampian), Aberdeen
Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust), Bristol
Western General Hospital (NHS Lothian), Edinburgh
East Suffolk and North Essex NHS Foundation Trust, Ipswich
Guy's and St Thomas' NHS Foundation Trust, London
University College London Hospital, London
The Christie NHS Foundation Trust, Manchester
The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral
East and North Hertfordshire NHS Trust, Northwood
Queens Hospital (Barking, Havering and Redbridge University Hospitals NHS Trust), Romford
Musgrove Park Hospital (Somerset NHS Foundation Trust), Taunton
Royal Cornwall Hospital Trust, Truro
Merck Sharp & Dohme LLC
INDUSTRY
University College, London
OTHER